The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.0M data for 1.3M Compounds and 9.5K Targets. Of those, 1.4M data for 679K Compounds and 4.6K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

10 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Biochemical and pharmacological profiling of the pro-survival protein Bcl-xL.EBI
University of Washington
Design, synthesis, and interaction study of quinazoline-2(1H)-thione derivatives as novel potential Bcl-xL inhibitors.EBI
Chinese Academy of Sciences
The discovery of small molecule chemical probes of Bcl-X(L) and Mcl-1.EBI
Entremed
Structure-Based Optimization of 3-Phenyl-EBI
Fudan University
Dual inhibitors of the pro-survival proteins Bcl-2 and Mcl-1 derived from natural compound meiogynin A.EBI
Paris-Saclay University
Small-molecule Mcl-1 inhibitors: Emerging anti-tumor agents.EBI
Hunan Provinc
Expanding the Cancer Arsenal with Targeted Therapies: Disarmament of the Antiapoptotic Bcl-2 Proteins by Small Molecules.EBI
University of Maryland
Inhibition of MCL-1 and/or BFL-1/A1BDB
Dana-Farber Cancer Institute
Small molecule inhibitors of MCL-1 and uses thereofBDB
The Regents of The University of Michigan
Structure of the BH3 domains from the p53-inducible BH3-only proteins Noxa and Puma in complex with Mcl-1.BDB
University of Otago